期刊文献+

甲状腺全切术治疗甲状腺乳头状癌43例临床观察 被引量:2

Clinical observation of total thyroidectomy in treatment of 43 cases of patients with thyroid papillary carcinoma
下载PDF
导出
摘要 目的探讨甲状腺全切术治疗甲状腺乳头状癌的临床疗效。方法回顾性分析2006年1月~2012年6月43例于本院行甲状腺全切术的甲状腺乳头状癌患者的临床资料。结果发生单侧暂时性喉返神经损伤4例,双侧暂时性喉返神经损伤1例,单侧永久性喉返神经损伤1例,因肿瘤侵犯术中切断造成;未发生喉上神经损伤、甲状旁腺功能低下等其他严重并发症,术后随访6个月~2年,未见肿瘤复发和远处转移。结论甲状腺全切除术治疗甲状腺乳头状癌清除癌变组织彻底,复发和远处转移率低,值得临床推广应用。 Objective To investigate the effect of total thyroidectomy in treatment of thyroid papillary carcinoma. Methods The clinical data of 43 patients with thyroid papillary carcinoma, who underwent total thyroidectomy in our hospital from January 2006 to June 2012, were retrospectively analyzed. Results Unilateral transient recurrent laryngeal nerve injury occurred in 4 cases, bilateral transient recurrent laryngeal nerve injury encountered in I case. Unilateral permanent recurrent laryngeal nerve injury occurred in 1 case, it was due to tumor invasion and abscission in operation. No serious complications happened, such as superior laryngeal nerve injury and hypothyroidism. During the period of postoperative follow up for 6 months to 2 years, no case occurred recurrence and distant metastasis. Conclusion Total thyroidectomy can thoroughly remove cancerous tissue and has low rate of recurrence and distant metastasis in treatment of thyroid papillary carcinoma.
出处 《中国当代医药》 2013年第14期58-59,共2页 China Modern Medicine
关键词 甲状腺全切术 甲状腺乳头状癌 疗效 临床 Total thyroidectomy Thyroid papillary carcinoma Effect Clinical
  • 相关文献

参考文献8

二级参考文献64

  • 1高力.浅论分化性甲状腺癌的甲状腺切除范围[J].实用临床医药杂志,2004,8(3):6-7. 被引量:13
  • 2Toubeau M,Touzery C,Arveux P,et al.Predictive value for disease progression of serum thyrogiohulin levels measured in the postoperative period and after 131^I ablation therapy in patients with differentiated thyroid cancer.J Nucl Med,2004,45:988-994.
  • 3Bemier MO,Morel O,Bodien P,et al.Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer.Eur J Nucl Med Mol Imaging,2005,32:1418-1421.
  • 4Kim TY,Kim WB,Kim ES,et al.Serum thyroglobulin levels at the time of 131Ⅰ remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with well-differentiated thyroid carcinoma.J Clin Endocrinol Metab,2005,90:1440-1445.
  • 5Heemstra KA,Liu YY,Stokkel M,et al.Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.Clin Endocrinol (Oxf),2007,66:58-64.
  • 6Cooper DS,Doherty GM,Haagen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancr:the American Thyroid Association Guidelines Taskforce.Thyroid,2006,16:109-142.
  • 7Pelizzo MR,Merante Boschin I,Toniato A,et al.Diagnosis,treatment,prognostic factors and long-term outcome in papillary thyroid carcinoma.Minerva Eedocrinol,2008,33:359-379.
  • 8Lundgren C,Hall P,Dickman P,et al.Clinically significant pingnostie factors for differentiated thyroid carcinoma:a populationbased,nested case-control study.Cancer,2006,106:524-531.
  • 9Bilimoria K,Bentrem D,Ko C,et al.Extent of surgery affects survival for papillary thyroid cancer.Ann Surg,2007,246:375-384.
  • 10Sawka AM,Orlov S,Gelberg J,et al.Prognostic value of poatsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.Head Neck,2008,30:693-700.

共引文献98

同被引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部